Pfizer and its BioNTech company will announce on March that the presentation of a formal health care regulator in the United States will begin for the emergence of its antiquated evacuation in nine months and five years.
If the state drug regulatory agency, the FDA, authorizes the dosing regimen, it will convert to the first vacuna anticovid available for this group stage in United States.
After the announcement, the FDA indicated in a statement that a meeting would be held on February 15 to consider the petition.
The companies are waiting for the authorization for only doses of their vaccine, but think that a third dose will be necessary “to increase the levels of protection against the current and possible future variants” of coronavirus, said Pfizer CEO Albert Bour in a communiqué.
“If the doses are authorized, the parents will take the opportunity to start a series of vacancies against Covid-19 in order to have the necessary authorization for a third dose,” he said.
Some experts have pronounced it against this strange medium.
Nonetheless, the FDA’s internal jefa, Janet Woodcock, defended March the need to advance rapidly: “Have a safe and effective vacancy available for the nines of this group and be a priority for the agency”, declared in a statement.
Reduced dose
The solicitation of Pfizer should be finally finalized “in the next days”, just the company. While the vaccine powder is available in the following weeks.
To limit secondary effects in this young group group, the pharmaceutical pharmaceutical giant significantly reduces the dosage of its vaccine, opting for only 3 micrograms per injection. In contrast, it takes 30 for the mayors of 12 years, and 10 for those between 5 and 11 years.
The company’s investigators concluded that the vaccine had been dosed for several weeks, up to two to five years, and announced in December that it would be adding a third dose in its infancy.
In these cases, the third dose should be summed up in less than two months after the second, with the first two doses being injected three times a week.
The data for the three-dose regimen are “expected in close months and will be submitted to the FDA to support a possible expansion” of its initial petition, appointed by Pfizer and BioNTech in a statement.
The Pfizer-BioNTech vaccine was approved three months ago for its use in emergencies from 5 to 11 years.
23 million dollars
The United States has about 23 million minor minorities within 5 years. With two years of pandemic, many desperate parents have to evacuate to their niños against the coronavirus.
However, the sanitary authorities are equally concerned about the great skepticism of other parents.
Vacation bags are very minor among nines. The vaccine is available from three months ago in United States for children between 5 and 11 years, at the moment only 30% of them have received at least one dose, and already 22% are completely vaccinated, according to the Centers for Control and the Prevention of Injuries (CDC).
The children are less likely to be seriously injured by Covid-19, but some are hospitalized.
Debit the number of infections raised, the bromine of the omicron variant sent a record number of nines to the hospital.
The small ones also can develop severe cases of multisystem pediatric inflammatory disease (MIS-C).
One 400 years from 0 to 4 years before death Covid-19 in the United States of America since the beginning of the pandemic, following the CDC figures.
Reference-www.eleconomista.com.mx